MSB 7.69% $1.19 mesoblast limited

MSB trading, page-1896

  1. 136 Posts.
    lightbulb Created with Sketch. 25
    From the 25/9 announcement - Mesoblast Cardiac Cell Therapy in Children "
    Full results of this Phase 2b trial will be presented by the trial’s independent
    investigators at an upcoming conference."

    This announcement spells POSITIVE all over 1. Boston Children Hospital believes in it. 2. Presenting the result at a conference should imply good result.

    Though ASX classified this as a non price sensitive but I think this announcement gives investors a lot of confidence.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.